About Latus Bio
Discover Latus’ groundbreaking gene therapy candidates, utilizing high-throughput screened AAV capsids to transform CNS disorder treatments through precision delivery. Latus’ innovative approach aims to target specific tissues, significantly enhancing safety and efficacy for patients.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-A
Global Headquarters
Philadelphia, United States
Team Size
11-50
Tracked Since
Sep 29, 2026
Web & Domain Identity
Official Website
latusbio.com
Domain Registered Date
Jun 10, 2022
Social & Network Presence
X / Twitter Profile
Not linked
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Raised $97,000,000 · Series-A
fundraisingfox.com
- Milestone
Website domain registered
latusbio.com
Investors & Backers
8VC
Ben Franklin Technology Partners
BioAdvance
DCVC Bio
Gaingels
Hatch Biofund Management
Helen’s Pink Sky Foundation
Korea Development Bank
Modi Ventures
Sahin Boydas
Funding History
Series-A
· May 4, 2026
$97,000,000 fundraisingfox.com
Founders & Leadership
Bethany Mancilla
Chief Business Officer
Work email & phone locked
Unlock →
Beverly L. Davidson
Founder
Work email & phone locked
Unlock →
Jang-Ho Cha
Chief Scientific Officer and Chief Marketing Officer
Work email & phone locked
Unlock →
John Connelly
Chief Development Officer
Work email & phone locked
Unlock →
Katie Hewitt
Interim Chief Business Officer
Work email & phone locked
Unlock →
P. Peter Ghoroghchian
Chief Executive Officer
Work email & phone locked
Unlock →
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026